-
1
-
-
0037092951
-
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludaribine: Results of a large international study
-
Keating M, Flinn I, Jain V, Binet J-L, Hillmen P, Byrd J, Albitar M Brettman L, Santabarbara P, Wacker B, et al. Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludaribine: results of a large international study. Blood 2002;99:3554-3561.
-
(2002)
Blood
, vol.99
, pp. 3554-3561
-
-
Keating, M.1
Flinn, I.2
Jain, V.3
Binet, J.-L.4
Hillmen, P.5
Byrd, J.6
Albitar, M.7
Brettman, L.8
Santabarbara, P.9
Wacker, B.10
-
2
-
-
0036683449
-
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)
-
Lundin J, Kimby E, Bjorkholm M, Broliden PA, Celsing F, Hjalmar V, Mollgard L, Rebello P, Hale G, Waldmann H et al. Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL). Blood 2002;100:768-773.
-
(2002)
Blood
, vol.100
, pp. 768-773
-
-
Lundin, J.1
Kimby, E.2
Bjorkholm, M.3
Broliden, P.A.4
Celsing, F.5
Hjalmar, V.6
Mollgard, L.7
Rebello, P.8
Hale, G.9
Waldmann, H.10
-
3
-
-
0037106502
-
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who have also received fludaribine
-
Rai K, Freter C, Mercier R. Alemtuzumab in previously treated chronic lymphocytic leukemia patients who have also received fludaribine. J Clin Oncol 2002;20:3891-3897.
-
(2002)
J. Clin. Oncol.
, vol.20
, pp. 3891-3897
-
-
Rai, K.1
Freter, C.2
Mercier, R.3
-
4
-
-
0032063012
-
Guillain - Barre syndrome and SIADH in a patient with chronic lymphocytic leukemia
-
Gutknecht D. Guillain - Barre syndrome and SIADH in a patient with chronic lymphocytic leukemia. J Am Board Fam Pract 1998;11:237-239.
-
(1998)
J. Am. Board Fam. Pract.
, vol.11
, pp. 237-239
-
-
Gutknecht, D.1
-
5
-
-
0030977187
-
Successful treatment of syndrome of inappropriate antidiuretic secretion (SIADH) in 2 patients with CNS involvement of chronic lymphocytic leukemia
-
Hagberg H, Lannemyr O, Acosta S, Birgegard G. Successful treatment of syndrome of inappropriate antidiuretic secretion (SIADH) in 2 patients with CNS involvement of chronic lymphocytic leukemia. Eur J Haematol 1997;58:207-208.
-
(1997)
Eur. J. Haematol.
, vol.58
, pp. 207-208
-
-
Hagberg, H.1
Lannemyr, O.2
Acosta, S.3
Birgegard, G.4
-
6
-
-
0033395571
-
Inappropriate secretion of antidiuretic hormone as the initial sign of central nervous system progression of nocardiosis in a patient with chronic lymphocytic leukemia
-
Ramila E, Martino R, Santamaria A, Sierra J. Inappropriate secretion of antidiuretic hormone as the initial sign of central nervous system progression of nocardiosis in a patient with chronic lymphocytic leukemia. Haematologica 1999;84: 1155-1156.
-
(1999)
Haematologica
, vol.84
, pp. 1155-1156
-
-
Ramila, E.1
Martino, R.2
Santamaria, A.3
Sierra, J.4
-
7
-
-
0035679115
-
Pituitary infiltration in B-cell chronic lymphocytic leukemia
-
Rye A, Stitson R, Dyer M. Pituitary infiltration in B-cell chronic lymphocytic leukemia. Br J Haematol 2001;115:718.
-
(2001)
Br. J. Haematol.
, vol.115
, pp. 718
-
-
Rye, A.1
Stitson, R.2
Dyer, M.3
-
8
-
-
0023234434
-
Chronic lymphocytic leukemic meningitis as a cause of the syndrome of inappropriate secretion of antidiuretic hormone
-
Stagg M, Gumbart C. Chronic lymphocytic leukemic meningitis as a cause of the syndrome of inappropriate secretion of antidiuretic hormone. Cancer 1987;60:191-192.
-
(1987)
Cancer
, vol.60
, pp. 191-192
-
-
Stagg, M.1
Gumbart, C.2
-
9
-
-
17544393810
-
Chlorambucil-induced inappropriate antiduresis in a man with chronic lymphocytic leukemia
-
Wagner A, Brunet S, Puig J, Ortega E, Subira M, Puig M. Chlorambucil-induced inappropriate antiduresis in a man with chronic lymphocytic leukemia. Ann Hematol 1999;78:37-38.
-
(1999)
Ann. Hematol.
, vol.78
, pp. 37-38
-
-
Wagner, A.1
Brunet, S.2
Puig, J.3
Ortega, E.4
Subira, M.5
Puig, M.6
|